"2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19": reply

J Thromb Haemost. 2024 Sep;22(9):2672-2673. doi: 10.1016/j.jtha.2024.06.009.
No abstract available

Keywords: COVID-19; COVID-19 vaccines; anticoagulants; critical illness; platelet aggregation inhibitors.

Publication types

  • Letter

MeSH terms

  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use
  • COVID-19 Drug Treatment
  • COVID-19* / blood
  • COVID-19* / complications
  • Fibrinolytic Agents* / administration & dosage
  • Fibrinolytic Agents* / adverse effects
  • Fibrinolytic Agents* / therapeutic use
  • Humans
  • Practice Guidelines as Topic*
  • SARS-CoV-2
  • Thrombosis / blood
  • Thrombosis / drug therapy
  • Thrombosis / prevention & control

Substances

  • Fibrinolytic Agents
  • Anticoagulants